{"id":86469,"date":"2020-11-12T19:17:00","date_gmt":"2020-11-12T19:17:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2760971"},"modified":"2020-11-12T19:17:00","modified_gmt":"2020-11-12T19:17:00","slug":"the-chinese-biopharmaceutical-contract-manufacturing-market-is-estimated-to-be-worth-usd-2-6-billion-in-2030-predicts-roots-analysis","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2020\/11\/12\/the-chinese-biopharmaceutical-contract-manufacturing-market-is-estimated-to-be-worth-usd-2-6-billion-in-2030-predicts-roots-analysis\/","title":{"rendered":"The Chinese biopharmaceutical contract manufacturing market is estimated to be worth USD 2.6 billion in 2030, predicts Roots Analysis"},"content":{"rendered":"<p><img decoding=\"async\" width=\"225\" height=\"225\" src=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/11\/4671-1605071008.jpg\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"\" loading=\"lazy\" style=\"display: block; margin-bottom: 5px; clear:both;max-width: 100%;\" link_thumbnail=\"\" \/><\/p>\n<p><em>The growing biopharma industry in China has resulted in the creation of lucrative business opportunities for contract service providers; region-specific advantages have also attracted several foreign sponsors entities over the last few years<\/em><\/p>\n<p><a href=\"https:\/\/www.rootsanalysis.com\/\">Roots Analysis<\/a> is pleased to announce the publication of its recent study, titled, &ldquo;<a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/china-biopharmaceutical-contract-manufacturing\/313.html\">China Biopharmaceutical Contract Manufacturing Market, 2020-2030<\/a>.&rdquo;<\/p>\n<p>The report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of biopharmaceuticals in China. The study also features a detailed analysis of key drivers and trends related to this evolving domain. In addition to other elements, the study includes:<\/p>\n<ul>\n<li>A detailed assessment of the current market landscape of companies offering contract manufacturing services for biopharmaceuticals in China.<\/li>\n<li>An analysis of the partnerships that have been established in this domain, in the recent past.<\/li>\n<li>An analysis of the expansion initiatives undertaken by contract manufacturers in China, in order to augment their capabilities, in the recent past.<\/li>\n<li>A detailed analysis of more than 1500 clinical trials related to biopharmaceuticals that have been \/ are being \/ are likely to be conducted in China.<\/li>\n<li>An estimate of the overall, installed capacity for manufacturing biopharmaceuticals, based on data reported by industry stakeholders in the public domain.<\/li>\n<li>An analysis of the initiatives of big biopharma players engaged in this domain.<\/li>\n<li>A qualitative analysis, highlighting the various factors that need to be taken into consideration by drug \/ therapy developers while deciding whether to manufacture their respective products in-house or engage the services of a CMO.<\/li>\n<li>Detailed profiles of key players that have a diverse range of capabilities for the development, manufacturing, and packaging of biopharmaceutical products.<\/li>\n<li>A case study comparing the key characteristics of large molecule and small molecule drugs.<\/li>\n<li>A discussion on industry affiliated trends, key drivers, and challenges, under a SWOT framework, which are likely to impact the evolution of this field.<\/li>\n<li>A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)<\/li>\n<\/ul>\n<p><strong>Type of Product<\/strong><\/p>\n<ul>\n<li>API<\/li>\n<li>FDF<\/li>\n<\/ul>\n<p><strong>Type of Expression System Used<\/strong><\/p>\n<ul>\n<li>Mammalian<\/li>\n<li>Microbial<\/li>\n<li>Others<\/li>\n<\/ul>\n<p><strong>Scale of Operation<\/strong><\/p>\n<ul>\n<li>Preclinical \/ Clinical<\/li>\n<li>Commercial<\/li>\n<\/ul>\n<p><strong>Size of Manufacturer<\/strong><\/p>\n<ul>\n<li>Small<\/li>\n<li>Mid-sized<\/li>\n<li>Large \/ Very Large<\/li>\n<\/ul>\n<p><strong>Type of Biologic<\/strong><\/p>\n<ul>\n<li>Antibody<\/li>\n<li>Vaccine<\/li>\n<li>Others<\/li>\n<\/ul>\n<p><strong>Key companies covered in the <a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/china-biopharmaceutical-contract-manufacturing\/313.html\">report<\/a><\/strong><\/p>\n<ul>\n<li>ChemPartner Biologics<\/li>\n<li>JHL Biotech<\/li>\n<li>JOINN Biologics<\/li>\n<li>MabPlex<\/li>\n<li>Mycenax Biotech<\/li>\n<li>WuXi AppTec<\/li>\n<\/ul>\n<p>For more information please click on the following link:<\/p>\n<p><a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/china-biopharmaceutical-contract-manufacturing\/313.html\">https:\/\/www.rootsanalysis.com\/reports\/view_document\/china-biopharmaceutical-contract-manufacturing\/313.html<\/a><\/p>\n<p><strong>Other Recent Offerings<\/strong><\/p>\n<ol>\n<li><a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/china-pharmaceutical-contract-manufacturing\/312.html\">China Pharmaceutical Contract Manufacturing Services Market, 2020-2030<\/a><\/li>\n<li><a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/microbiome-contract-manufacturing\/306.html\">Live Biotherapeutics Products and Microbiome Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030<\/a><\/li>\n<li><a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/oligonucleotide-synthesis\/304.html\">Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030<\/a><\/li>\n<\/ol>\n<p><strong>About Roots Analysis<\/strong><\/p>\n<p>Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you&rsquo;d like help with your growing business needs, get in touch at info@rootsanalysis.com<\/p>\n<p><strong>Contact Information<\/strong><\/p>\n<p>Roots Analysis Private Limited<\/p>\n<p>Gaurav Chaudhary<\/p>\n<p>+1 (415) 800 3415<\/p>\n<p>gaurav.chaudhary@rootsanalysis.com<\/p>\n<p class=\"tags\">Tags: <a href=\"https:\/\/icrowdnewswire.com\/tag\/contract-manufacturing\/\" rel=\"tag\">contract manufacturing<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/roots-analysis\/\" rel=\"tag\">Roots Analysis<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/report\/\" rel=\"tag\">report<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/pharma-companies-in-china\/\" rel=\"tag\">pharma companies in china<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/pharma-intermediates\/\" rel=\"tag\">pharma intermediates<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/cmo\/\" rel=\"tag\">CMO<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/research\/\" rel=\"tag\">Research<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/analysis\/\" rel=\"tag\">Analysis<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/373164\/\" rel=\"tag\"><\/a><\/p>\n<div><strong>See Campaign: <\/strong><a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/china-biopharmaceutical-contract-manufacturing\/3\" target=\"_blank\">https:\/\/www.rootsanalysis.com\/reports\/view_document\/china-biopharmaceutical-contract-manufacturing\/3<\/a><br \/><b>Contact Information:<\/b><br \/>Contact:<br \/>\nGaurav Chaudhary<br \/>\ngaurav.chaudhary@rootsanalysis.com<\/p>\n<p>Roots Analysis<br \/>\nA430, 4th Floor,<br \/>\nBestech Business Towers, Sector 66, Mohali, India<br \/>\nsales@rootsanalysis.com<br \/>\n+1 (415) 800 3415<br \/>\n+44 (122) 391 1091<br \/>\nWeb: https:\/\/www.rootsanalysis.com\/<br \/>\nLinkedIn: https:\/\/in.linkedin.com\/company\/roots-analysis<br \/>\nTwitter: https:\/\/twitter.com\/RootsAnalysis<\/p>\n<p><b>Tags:<\/b><br \/><a href=\"\"><\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/reportedtimes\/\" rel=\"category tag\">Reportedtimes<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/ips\/\" rel=\"category tag\">IPS<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/extended-distribution\/\" rel=\"category tag\">Extended Distribution<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/icn-internal-distribution\/\" rel=\"category tag\">iCN Internal Distribution<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/wire\/\" rel=\"category tag\">Wire<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/research-newswire\/\" rel=\"category tag\">Research Newswire<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/language\/english\/\" rel=\"category tag\">English<\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"\" alt=\"image\" width=\"400\" height=\"300\" class=\"cwdfimg\" \/><\/div>\n<div>\n<h3>Contact Information:<\/h3>\n<p>Contact:<br \/>\nGaurav Chaudhary<br \/>\ngaurav.chaudhary@rootsanalysis.com<\/p>\n<p>Roots Analysis<br \/>\nA430, 4th Floor,<br \/>\nBestech Business Towers, Sector 66, Mohali, India<br \/>\nsales@rootsanalysis.com<br \/>\n+1 (415) 800 3415<br \/>\n+44 (122) 391 1091<br \/>\nWeb: https:\/\/www.rootsanalysis.com\/<br \/>\nLinkedIn: https:\/\/in.linkedin.com\/company\/roots-analysis<br \/>\nTwitter: https:\/\/twitter.com\/RootsAnalysis<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" width=\"225\" height=\"225\" src=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/11\/4671-1605071008.jpg\" alt=\"\">The growing biopharma industry in China has resulted in the creation of lucrative business opportunities for contract service providers; region-specific advantages have also attracted several foreign sponsors entities over the last few years Roots Analysis is pleased to announce the publication of its recent study, titled, &ldquo;China Biopharmaceutical Contract Manufacturing Market, 2020-2030.&rdquo; The report features &hellip; <a href=\"https:\/\/icrowdnewswire.com\/2020\/11\/12\/the-chinese-biopharmaceutical-contract-manufacturing-market-is-estimated-to-be-worth-usd-2-6-billion-in-2030-predicts-roots-analysis\/\">Continue reading <span>The Chinese biopharmaceutical contract manufacturing market is estimated to be worth USD 2.6 billion in 2030, predicts Roots Analysis<\/span><\/a> <a href=\"https:\/\/ipsnews.net\/business\/2020\/11\/12\/the-chinese-biopharmaceutical-contract-manufacturing-market-is-estimated-to-be-worth-usd-2-6-billion-in-2030-predicts-roots-analysis\/\" class=\"more-link\">Continue Reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":248,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3,5,67,57,64,4,54],"tags":[],"class_list":["post-86469","post","type-post","status-publish","format-standard","hentry","category-english","category-extended-distribution","category-icn-internal-distribution","category-ips","category-reportedtimes","category-research-newswire","category-wire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>The Chinese biopharmaceutical contract manufacturing market is estimated to be worth USD 2.6 billion in 2030, predicts Roots Analysis - Business<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/ipsnews.net\/business\/2020\/11\/12\/the-chinese-biopharmaceutical-contract-manufacturing-market-is-estimated-to-be-worth-usd-2-6-billion-in-2030-predicts-roots-analysis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Chinese biopharmaceutical contract manufacturing market is estimated to be worth USD 2.6 billion in 2030, predicts Roots Analysis - Business\" \/>\n<meta property=\"og:description\" content=\"The growing biopharma industry in China has resulted in the creation of lucrative business opportunities for contract service providers; region-specific advantages have also attracted several foreign sponsors entities over the last few years Roots Analysis is pleased to announce the publication of its recent study, titled, &ldquo;China Biopharmaceutical Contract Manufacturing Market, 2020-2030.&rdquo; The report features &hellip; Continue reading The Chinese biopharmaceutical contract manufacturing market is estimated to be worth USD 2.6 billion in 2030, predicts Roots Analysis Continue Reading &rarr;\" \/>\n<meta property=\"og:url\" content=\"http:\/\/ipsnews.net\/business\/2020\/11\/12\/the-chinese-biopharmaceutical-contract-manufacturing-market-is-estimated-to-be-worth-usd-2-6-billion-in-2030-predicts-roots-analysis\/\" \/>\n<meta property=\"og:site_name\" content=\"Business\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-12T19:17:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/11\/4671-1605071008.jpg\" \/>\n<meta name=\"author\" content=\"roots.analysis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"roots.analysis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/ipsnews.net\/business\/2020\/11\/12\/the-chinese-biopharmaceutical-contract-manufacturing-market-is-estimated-to-be-worth-usd-2-6-billion-in-2030-predicts-roots-analysis\/\",\"url\":\"http:\/\/ipsnews.net\/business\/2020\/11\/12\/the-chinese-biopharmaceutical-contract-manufacturing-market-is-estimated-to-be-worth-usd-2-6-billion-in-2030-predicts-roots-analysis\/\",\"name\":\"The Chinese biopharmaceutical contract manufacturing market is estimated to be worth USD 2.6 billion in 2030, predicts Roots Analysis - Business\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#website\"},\"primaryImageOfPage\":{\"@id\":\"http:\/\/ipsnews.net\/business\/2020\/11\/12\/the-chinese-biopharmaceutical-contract-manufacturing-market-is-estimated-to-be-worth-usd-2-6-billion-in-2030-predicts-roots-analysis\/#primaryimage\"},\"image\":{\"@id\":\"http:\/\/ipsnews.net\/business\/2020\/11\/12\/the-chinese-biopharmaceutical-contract-manufacturing-market-is-estimated-to-be-worth-usd-2-6-billion-in-2030-predicts-roots-analysis\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/11\/4671-1605071008.jpg\",\"datePublished\":\"2020-11-12T19:17:00+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/99a172f95a70a5b8135ddad53fdf2451\"},\"breadcrumb\":{\"@id\":\"http:\/\/ipsnews.net\/business\/2020\/11\/12\/the-chinese-biopharmaceutical-contract-manufacturing-market-is-estimated-to-be-worth-usd-2-6-billion-in-2030-predicts-roots-analysis\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/ipsnews.net\/business\/2020\/11\/12\/the-chinese-biopharmaceutical-contract-manufacturing-market-is-estimated-to-be-worth-usd-2-6-billion-in-2030-predicts-roots-analysis\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/ipsnews.net\/business\/2020\/11\/12\/the-chinese-biopharmaceutical-contract-manufacturing-market-is-estimated-to-be-worth-usd-2-6-billion-in-2030-predicts-roots-analysis\/#primaryimage\",\"url\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/11\/4671-1605071008.jpg\",\"contentUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/11\/4671-1605071008.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/ipsnews.net\/business\/2020\/11\/12\/the-chinese-biopharmaceutical-contract-manufacturing-market-is-estimated-to-be-worth-usd-2-6-billion-in-2030-predicts-roots-analysis\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/business\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Chinese biopharmaceutical contract manufacturing market is estimated to be worth USD 2.6 billion in 2030, predicts Roots Analysis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/business\/#website\",\"url\":\"https:\/\/ipsnews.net\/business\/\",\"name\":\"Business\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/business\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/99a172f95a70a5b8135ddad53fdf2451\",\"name\":\"roots.analysis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7f98002c4347627ab3e788c29a8a843cd26aa1504a8cd35e524fddd188793bee?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7f98002c4347627ab3e788c29a8a843cd26aa1504a8cd35e524fddd188793bee?s=96&d=mm&r=g\",\"caption\":\"roots.analysis\"},\"sameAs\":[\"https:\/\/icrowdnewswire.com\/ips\"],\"url\":\"https:\/\/ipsnews.net\/business\/author\/roots-analysis\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Chinese biopharmaceutical contract manufacturing market is estimated to be worth USD 2.6 billion in 2030, predicts Roots Analysis - Business","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/ipsnews.net\/business\/2020\/11\/12\/the-chinese-biopharmaceutical-contract-manufacturing-market-is-estimated-to-be-worth-usd-2-6-billion-in-2030-predicts-roots-analysis\/","og_locale":"en_US","og_type":"article","og_title":"The Chinese biopharmaceutical contract manufacturing market is estimated to be worth USD 2.6 billion in 2030, predicts Roots Analysis - Business","og_description":"The growing biopharma industry in China has resulted in the creation of lucrative business opportunities for contract service providers; region-specific advantages have also attracted several foreign sponsors entities over the last few years Roots Analysis is pleased to announce the publication of its recent study, titled, &ldquo;China Biopharmaceutical Contract Manufacturing Market, 2020-2030.&rdquo; The report features &hellip; Continue reading The Chinese biopharmaceutical contract manufacturing market is estimated to be worth USD 2.6 billion in 2030, predicts Roots Analysis Continue Reading &rarr;","og_url":"http:\/\/ipsnews.net\/business\/2020\/11\/12\/the-chinese-biopharmaceutical-contract-manufacturing-market-is-estimated-to-be-worth-usd-2-6-billion-in-2030-predicts-roots-analysis\/","og_site_name":"Business","article_published_time":"2020-11-12T19:17:00+00:00","og_image":[{"url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/11\/4671-1605071008.jpg","type":"","width":"","height":""}],"author":"roots.analysis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"roots.analysis","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/ipsnews.net\/business\/2020\/11\/12\/the-chinese-biopharmaceutical-contract-manufacturing-market-is-estimated-to-be-worth-usd-2-6-billion-in-2030-predicts-roots-analysis\/","url":"http:\/\/ipsnews.net\/business\/2020\/11\/12\/the-chinese-biopharmaceutical-contract-manufacturing-market-is-estimated-to-be-worth-usd-2-6-billion-in-2030-predicts-roots-analysis\/","name":"The Chinese biopharmaceutical contract manufacturing market is estimated to be worth USD 2.6 billion in 2030, predicts Roots Analysis - Business","isPartOf":{"@id":"https:\/\/ipsnews.net\/business\/#website"},"primaryImageOfPage":{"@id":"http:\/\/ipsnews.net\/business\/2020\/11\/12\/the-chinese-biopharmaceutical-contract-manufacturing-market-is-estimated-to-be-worth-usd-2-6-billion-in-2030-predicts-roots-analysis\/#primaryimage"},"image":{"@id":"http:\/\/ipsnews.net\/business\/2020\/11\/12\/the-chinese-biopharmaceutical-contract-manufacturing-market-is-estimated-to-be-worth-usd-2-6-billion-in-2030-predicts-roots-analysis\/#primaryimage"},"thumbnailUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/11\/4671-1605071008.jpg","datePublished":"2020-11-12T19:17:00+00:00","author":{"@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/99a172f95a70a5b8135ddad53fdf2451"},"breadcrumb":{"@id":"http:\/\/ipsnews.net\/business\/2020\/11\/12\/the-chinese-biopharmaceutical-contract-manufacturing-market-is-estimated-to-be-worth-usd-2-6-billion-in-2030-predicts-roots-analysis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/ipsnews.net\/business\/2020\/11\/12\/the-chinese-biopharmaceutical-contract-manufacturing-market-is-estimated-to-be-worth-usd-2-6-billion-in-2030-predicts-roots-analysis\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/ipsnews.net\/business\/2020\/11\/12\/the-chinese-biopharmaceutical-contract-manufacturing-market-is-estimated-to-be-worth-usd-2-6-billion-in-2030-predicts-roots-analysis\/#primaryimage","url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/11\/4671-1605071008.jpg","contentUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/11\/4671-1605071008.jpg"},{"@type":"BreadcrumbList","@id":"http:\/\/ipsnews.net\/business\/2020\/11\/12\/the-chinese-biopharmaceutical-contract-manufacturing-market-is-estimated-to-be-worth-usd-2-6-billion-in-2030-predicts-roots-analysis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/business\/"},{"@type":"ListItem","position":2,"name":"The Chinese biopharmaceutical contract manufacturing market is estimated to be worth USD 2.6 billion in 2030, predicts Roots Analysis"}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/business\/#website","url":"https:\/\/ipsnews.net\/business\/","name":"Business","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/business\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/99a172f95a70a5b8135ddad53fdf2451","name":"roots.analysis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7f98002c4347627ab3e788c29a8a843cd26aa1504a8cd35e524fddd188793bee?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7f98002c4347627ab3e788c29a8a843cd26aa1504a8cd35e524fddd188793bee?s=96&d=mm&r=g","caption":"roots.analysis"},"sameAs":["https:\/\/icrowdnewswire.com\/ips"],"url":"https:\/\/ipsnews.net\/business\/author\/roots-analysis\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/86469","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/users\/248"}],"replies":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/comments?post=86469"}],"version-history":[{"count":9,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/86469\/revisions"}],"predecessor-version":[{"id":86799,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/86469\/revisions\/86799"}],"wp:attachment":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/media?parent=86469"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/categories?post=86469"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/tags?post=86469"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}